About the Book
Former CIA sniper Kadance Tolle possesses a special set of skills and a rare pedigree. She comes from a family of assassins, and by saving Lyndon Vaile’s life she risks being found by them. Despite the danger, Kadance feels compelled to help Lyndon discover who is after him–and his research that seems to prove that the Ebola virus was manmade and is about to be weaponized.
With shadowy figures pursuing them and a Mastermind watching their every move, Kadance and Lyndon must scramble to stop an impending bioattack at the State of the Union address. But their warnings fall on deaf ears, and it becomes increasingly clear that there’s no one they can trust–except perhaps each other.
Strap in for a breakneck story that will have you up all night, hurtling toward the last page as the clock ticks and time runs out.
In My Opinion
The premise for Melissa Koslin’s debut novel is intriguing, and as a fan of romantic suspense, I looked forward to reading Never Miss. However, this book does just that.
The overuse of the word perfect to describe the characters grated on me and there were some timeline issues that were glaring and sometimes repetitive. The lead up to big moments too often fizzled instead of sizzled, and some elements of the plot were just too unbelievable to get on board with.
However, for those who enjoy a fast-paced read with a strong and intelligent female lead and a hero who matches her in the brains department, Never Miss is entertaining (consider it akin to a spy movie where impossible situations are easily escaped). And I did love Kadence’s cat throughout this book. Mack definitely left the biggest impression with me in the end.
With this being Koslin’s first book, I’m not giving up on her. I’ll see what the next book brings as authors improve their craft with time and practice.
I receive complimentary books from publishers, publicists, and/or authors, including NetGalley. I am not required to write positive reviews. The opinions I have expressed are my own. I am disclosing this in accordance with the Federal Commission’s 16 CFR, Part 255.